Browsing Tag
United Kingdom
645 posts
LTIMindtree bags digital transformation deal from Currys plc
Indian tech firm LTIMindtree has bagged a multi-million-dollar deal from British consumer electronics company Currys plc to serve…
DRAGON SAF project : Technip Energies bags FEED contract from LanzaTech
Technip Energies has bagged a contract for the front end engineering design (FEED) phase from LanzaTech UK for…
SSEN Transmission receives Ofgem approval for Orkney subsea link, unlocking Scotland’s final island group
Find out how SSEN Transmission’s Orkney link approval marks a pivotal step in connecting Scotland’s islands and accelerating renewable energy goals.
Essar Group makes $3.6bn bet on clean energy future across the UK and India
Find out how Essar Group’s new $3.6 billion push into hydrogen, biofuels, and green ammonia aims to transform the UK and India’s low-carbon energy future.
Wipro to help Menzies Aviation transform air cargo services
Wipro said that it has been roped in by London-based aviation services company Menzies Aviation for the transformation…
Gallagher Re acquires Lloyd’s broker Bay Risk Services
Arthur J. Gallagher & Co., through its reinsurance unit Gallagher Re, has acquired the business and assets of…
Equinor seals $850m deal for Suncor’s UK assets to deepen North Sea strategy
Find out how Equinor’s $850M acquisition of Suncor Energy’s UK assets boosts its Rosebank stake and deepens its energy role in the North Sea.
RWE advances UK solar and battery pipelines with JBM Solar acquisition
RWE, a German renewables developer, has acquired JBM Solar, an independent solar and co-located battery developers, to expand…
Thales selects L&T Technology Services for 5G-driven connectivity solutions for urban railways
L&T Technology Services (LTTS) said that it has been selected by Thales to provide 5G-driven next-generation connectivity solutions…
Clinical-stage Redx Pharma, Jounce Therapeutics sign $425m merger deal
Redx Pharma, a UK-based clinical-stage biotechnology company, and Jounce Therapeutics, a Nasdaq-listed clinical-stage immunotherapy company, have agreed to…